Early treatment with Copaxone ‘benefits patients’
Posted: Fri Apr 24, 2015 1:47 am
Teva has announced new data on the safety and efficacy of Copaxone (glatiramer acetate injection) 40mg/mL in patients with relapsing forms of multiple sclerosis (MS)..... Read More - http://www.ms-uk.org/copaxone